Literature DB >> 23629745

Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women.

Yue Jiang1, Jiaping Chen, Jiangping Wu, Zhibin Hu, Zhenzhen Qin, Xiao'an Liu, Xiaoxiang Guan, Yanru Wang, Jing Han, Tao Jiang, Guangfu Jin, Mingfeng Zhang, Hongxia Ma, Shui Wang, Hongbing Shen.   

Abstract

MicroRNAs (miRNA) are a class of small, noncoding RNA molecules involved in a diversity of cellular functions. Single nucleotide polymorphisms (SNPs) in miRNA biosynthesis genes may affect the biogenesis of miRNAs and consequently affect the miRNAs regulation. In this study, we systematically selected 24 functional SNPs located in eight key biosynthesis genes of miRNA (DROSHA, DGCR8, RAN, DICER, AGO2, GEMIN3, GEMIN4 and HIWI) and investigated the association between these SNPs and the risk of breast cancer in a Chinese population. All 24 SNPs were firstly genotyped in stage 1 (878 cases and 900 controls) and three promising SNPs (DROSHA rs2291109, RAN rs7301722 and DGCR8 rs417309) were selected for further validation in stage 2 (914 cases and 967 controls). We found that only one SNP (rs417309) located in the 3'-UTR of DGCR8 was consistently associated with an increased breast cancer risk in two stages with a combined odds ratio (OR) of 1.50 [95% confidence interval (CI) = 1.16-1.93]. Based on the bioinformatics prediction, rs417309 is located at the binding sites of miR-106b and miR-579 in the 3'-UTR of DGCR8. To evaluate whether rs417309 variant affects the binding capacity of miRNAs, we cotransfected luciferase reporter plasmids of DGCR8 3'-UTR and miR-106b/miR-579 in three cell lines. Luciferase activity assay showed a higher expression level with rs417309 A allele compared with G allele in MCF-7 cell lines (p = 3.31 × 10(-7) , 9.29 × 10(-7) for miR-106b and miR-579, respectively). Our findings suggested that DGCR8 rs417309 G > A might affect breast cancer risk through the interruption of miRNA binding.
© 2013 UICC.

Entities:  

Keywords:  DGCR8; breast cancer risk; miRNA biosynthesis genes

Mesh:

Substances:

Year:  2013        PMID: 23629745     DOI: 10.1002/ijc.28237

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

Review 1.  The role of microRNAs in human breast cancer progression.

Authors:  WenCheng Zhang; Jinbo Liu; Guangshun Wang
Journal:  Tumour Biol       Date:  2014-06-18

2.  Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry.

Authors:  Frank Qian; Ye Feng; Yonglan Zheng; Temidayo O Ogundiran; Oladosu Ojengbede; Wei Zheng; William Blot; Christine B Ambrosone; Esther M John; Leslie Bernstein; Jennifer J Hu; Regina G Ziegler; Sarah Nyante; Elisa V Bandera; Sue A Ingles; Michael F Press; Katherine L Nathanson; Anselm Hennis; Barbara Nemesure; Stefan Ambs; Laurence N Kolonel; Olufunmilayo I Olopade; Christopher A Haiman; Dezheng Huo
Journal:  Hum Genet       Date:  2016-07-05       Impact factor: 4.132

3.  MiR-2964a-5p binding site SNP regulates ATM expression contributing to age-related cataract risk.

Authors:  Han Rong; Shanshan Gu; Guowei Zhang; Lihua Kang; Mei Yang; Junfang Zhang; Xinyue Shen; Huaijin Guan
Journal:  Oncotarget       Date:  2017-05-03

4.  miRNA-Processing Gene Methylation and Cancer Risk.

Authors:  Brian T Joyce; Yinan Zheng; Zhou Zhang; Lei Liu; Masha Kocherginsky; Robert Murphy; Chad J Achenbach; Jonah Musa; Firas Wehbe; Allan Just; Jincheng Shen; Pantel Vokonas; Joel Schwartz; Andrea A Baccarelli; Lifang Hou
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-02-23       Impact factor: 4.254

5.  Association of Polymorphic Variants of miRNA Processing Genes with Larynx Cancer Risk in a Polish Population.

Authors:  Ewa Osuch-Wojcikiewicz; Antoni Bruzgielewicz; Kazimierz Niemczyk; Olga Sieniawska-Buccella; Alicja Nowak; Anna Walczak; Ireneusz Majsterek
Journal:  Biomed Res Int       Date:  2015-11-25       Impact factor: 3.411

6.  Genetic variants in the MicroRNA biosynthetic pathway Gemin3 and Gemin4 are associated with a risk of cancer: a meta-analysis.

Authors:  Wenbo Zhu; Jun Zhao; Jieyu He; Daxun Qi; Lina Wang; Xu Ma; Pei Liu
Journal:  PeerJ       Date:  2016-03-15       Impact factor: 2.984

7.  Genetic variants in lncRNA SRA and risk of breast cancer.

Authors:  Rui Yan; Kaijuan Wang; Rui Peng; Shuaibing Wang; Jingjing Cao; Peng Wang; Chunhua Song
Journal:  Oncotarget       Date:  2016-04-19

8.  A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population.

Authors:  Jiali Xu; Zhiqiang Yin; Hong Shen; Wen Gao; Yingying Qian; Dong Pei; Lingxiang Liu; Yongqian Shu
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

9.  MicroRNA biogenesis pathway genes polymorphisms and cancer risk: a systematic review and meta-analysis.

Authors:  Jieyu He; Jun Zhao; Wenbo Zhu; Daxun Qi; Lina Wang; Jinfang Sun; Bei Wang; Xu Ma; Qiaoyun Dai; Xiaojin Yu
Journal:  PeerJ       Date:  2016-12-07       Impact factor: 2.984

10.  Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia.

Authors:  Aleksandra Butrym; Piotr Łacina; Kazimierz Kuliczkowski; Katarzyna Bogunia-Kubik; Grzegorz Mazur
Journal:  BMC Cancer       Date:  2018-01-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.